Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mutant idh1 inhibitor'

Search results for: 'mutant idh1 inhibitor'

Items 51-60 of 172

Page
per page
  1. XL388
    A3940 XL388
    Summary: MTOR inhibitor,highly potent and selective
      insoluble in EtOH; insoluble in H2O; ≥6.87 mg/mL
  2. Palomid 529
    A8618 Palomid 529
    Summary: PI3K/Akt/mTOR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
  3. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1/PKA/CDK2 inhibitor,potent and selective
      insoluble in EtOH; ≥23.8 mg/mL
  4. LY 303511
    A3568 LY 303511
    Summary: MTOR inhibitor
      Soluble in DMSO
  5. PI-3065
    B4660 PI-3065
    Target: PI3K
    Summary: P110δkinase inhibitor
      ≥22.7 mg/mL
  6. PIK-93
    A5449 PIK-93
    Summary: PI3Kγ/PI4KIIIβ/PI3Kα inhibitor
      insoluble in H2O; ≥19.5 mg/mL
  7. OTSSP167 hydrochloride
    B1308 OTSSP167 hydrochloride
    Summary: MELK inhibitor,highly potent and selective
      Soluble in DMSO
  8. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL
  9. KU-0063794
    A5078 KU-0063794
    Target: mTOR
    Summary: MTORC1 and mTORC2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.65 mg/mL
  10. TTP 22
    A3894 TTP 22
     1 Citation
    Target: CK2
    Summary: CK2 inhibitor
      insoluble in H2O; ≥16.5 mg/mL

Items 51-60 of 172

Page
per page
Shop By
Now Shopping by
  1. Category PI3K/Akt/mTOR Signaling Remove This Item
Clear All
Shopping Options
Category
  1. Akt 26item
  2. AMPK 5item
  3. CK2 8item
  4. DNA-PK 5item
  5. eNOS 2item
  6. GSK-3 17item
  7. MELK 2item
  8. mTOR 29item
  9. PI3K 60item
  10. PI4K 1 item
  11. PDK-1 8item
  12. PIKfyve 1 item
  13. PKB 1 item
  14. S6 Kinase 8item
Specificity
  1. Selective 61item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 13item
  4. PI3K 35item
  5. mTOR 22item
  6. GSK-3 10item
  7. Eph Receptors 1 item
  8. VEGFR 1 item
  9. PDGFR 1 item
  10. Bcr-Abl 1 item
  11. Pim 1 item
  12. Ribosomal s6 kinases (RSK) 1 item
  13. Src 1 item
  14. DNA-PK 8item
  15. AMPK 2item
  16. S6 kinases 1 item
  17. ERK 1 item
  18. PKC 2item
  19. PKG 1 item
  20. PKA 3item
  21. MELK 1 item
  22. NUAK1 1 item
  23. NUAK2 1 item
  24. RSK 1 item
  25. ATM/ATR 2item
  26. CK2 3item
  27. HIPK2 1 item
  28. HIPK3 1 item
  29. P110 1 item
  30. Hck 1 item
  31. p70 rsk 3item
  32. PDK-1 1 item
  33. Prk 1 item
  34. NUAK 1 item
  35. NOS 1 item
  36. PIM1 kinase 1 item
  37. phospholipase A2 1 item
  38. ATM 1 item
  39. PIKfyve 1 item
  40. p90 S6K 1 item
Reported Experiments
  1. Animal Experiments 79item
  2. Cell Experiments 60item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 14item
  5. Cancer 50item
  6. Cervical Cancer 1 item
  7. Cholangiocarcinoma 1 item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 3item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 2item
  12. Diabetes 1 item
  13. Glioblastoma 5item
  14. Glioma 5item
  15. Hepatocellular Carcinoma 1 item
  16. Leukemia 1 item
  17. Lung Cancer 6item
  18. Melanoma 2item
  19. Neuroblastoma 2item
  20. Non-small Cell Lung Cancer 1 item
  21. Ovarian Cancer 4item
  22. Pancreatic Cancer 6item
  23. Prostate Cancer 5item
  24. Renal Cancer 1 item
  25. Rheumatoid Arthritis 1 item
  26. Type 2 Diabetes 1 item